galactosamine has been researched along with tofacitinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, K; Li, L; Lin, L; Ma, Y; Shao, R; Tang, L; Yang, Y; Zhang, L; Zhang, X; Zhu, M | 1 |
1 other study(ies) available for galactosamine and tofacitinib
| Article | Year |
|---|---|
Janus kinase inhibitor Tofacitinib alleviated acute hepatitis induced by lipopolysaccharide/D-galactosamine in mice.
Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Cytokines; Galactosamine; Hepatitis; Inflammation; Janus Kinase Inhibitors; Janus Kinases; Lipopolysaccharides; Liver; Mice; Tumor Necrosis Factor-alpha | 2023 |